Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (XQ) maintained out to 3 years post treatment with AAV-hAQP1 for both bilateral and unilateral ...
E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3", "E3 Lithium" or the "Company," a leader in Canadian lithium development, has completed well development and pump installation and is now ...
D3 Bio Inc., a global clinical-stage biotechnology company dedicated to developing innovative oncology therapeutics, today announced new phase 2 clinical data from its lead asset elisrasib (D3S-001), ...
District consolidation creates drill-ready targets along historic property boundaries where over 50 million ounces of past silver production occurred on either side of claim lines no single operator ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data from two ...
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to a reduction in lesion size and allowed some ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated Phase 1 (RMC-9805-001) ...
The New Orleans Saints have selected defensive back TJ Hall in Round 7 of the 2026 NFL Draft -- a big, physical DB who brings ...
Cellenkos®, Inc., a clinical-stage biotechnology company, developing allogeneic, tissue-targeted regulatory T cell (Treg) ...
Finally on Saturday the NFL got to the real meat-and-potatoes for diehard fans of the Draft. How did the Colts final 6 picks ...
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results